Efficacy of Cipargamin (KAE609) in a Randomized, Phase II Dose-Escalation Study in Adults in Sub-Saharan Africa With Uncomplicated Plasmodium falciparum Malaria

DSpace Repository

Efficacy of Cipargamin (KAE609) in a Randomized, Phase II Dose-Escalation Study in Adults in Sub-Saharan Africa With Uncomplicated Plasmodium falciparum Malaria

Author: Schmitt, Esther K.; Ndayisaba, Gilles; Yeka, Adoke; Asante, Kwaku Poku; Grobusch, Martin P.; Karita, Etienne; Mugerwa, Henry; Asiimwe, Stephen; Oduro, Abraham; Fofana, Bakary; Doumbia, Seydou; Su, Guoqin; Renner, Katalin Csermak; Venishetty, Vinay Kumar; Sayyed, Sarfaraz; Straimer, Judith; Demin, Ivan; Barsainya, Sarita; Boulton, Caroline; Gandhi, Preetam
Tübinger Autor(en):
Grobusch, Martin
Published in: Clinical Infectious Diseases (2022), Bd. 74, H. 10, S. 1831-1839
Verlagsangabe: Oxford Univ Press Inc
Language: English
Full text: http://dx.doi.org/10.1093/cid/ciab716
ISSN: 1058-4838
DDC Classifikation: 570 - Life sciences; biology
610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)